Results 141 to 150 of about 33,889 (223)

Ubiquitin-conjugating Enzymes in Cancer. [PDF]

Int J Biol Sci
Yao Z, Peng T, Dong H, Liao Y, Miao K, Qin JJ, Guan X.   +6 more
europepmc   +1 more source

Hairy cell leukemia: a chronic B-cell lymphoma with unique clinicopathological features and unresolved molecular mechanisms. [PDF]

Blood Adv
Zhang G, Hu J.
europepmc   +1 more source

Inactivation of CDK4/6, CDK2, and ERK in G1-phase triggers differentiation commitment. [PDF]

Commun Biol
Sharma S, Berger H, Meyer T, Teruel MN.
europepmc   +1 more source

The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression [PDF]

, 2002
Cole, M. D., Kotenko, I., Obaya González, Álvaro Jesús, Sedivy, John M.   +3 more
core   +1 more source

Focal Adhesion and Cancer Cell Cycle-Associated Resistance. [PDF]

ACS Omega
Ruksha TG, Palkina NV, Lapkina EZ, Liu K.   +3 more
europepmc   +1 more source

Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. [PDF]

Mol Biomed
Wan Q, Yang Z, Huang L, Xia Y, Long L, Xu Z, Li J.   +6 more
europepmc   +1 more source

YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade. [PDF]

Drug Des Devel Ther
Wang W, Zhang Y, Jia X, Han L, Xin M.
europepmc   +1 more source

Targeting tumor dormancy: the next frontier in gastrointestinal stromal tumor therapy. [PDF]

Neoplasia
Wu S, Liu H, Yin Y, Li J, Zhang Z, Li W, Fu Y.   +6 more
europepmc   +1 more source

The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RCC. [PDF]

Neoplasia
Kuroda S, Funasaki S, Nishizawa H, Schmidt LS, Kurahashi R, Ito T, Arima Y, Tanaka M, Kitada A, James AM, Hasumi H, Jikuya R, Makiyama K, Kurotaki D, Minami T, Difilippantonio S, Linehan WM, Oike Y, Sawa T, Tanaka Y, Suda T, Yokokawa R, Nakamura T, Baba M, Kamba T.   +24 more
europepmc   +1 more source

Targeting ICMT: A promising strategy in cancer treatment (Review). [PDF]

Oncol Lett
Hu J, Xiao Y, Tang J.
europepmc   +1 more source